Nonpeptidic ligands for peptide and protein receptors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (51)
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
1998 • 1,067 citations
Rapid Identification of Subtype-Selective Agonists of the Somatostatin Receptor Through Combinatorial Chemistry
1998 • 455 citations
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.
1998 • 319 citations
Peptidomimetic design
1998 • 239 citations
Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist
1998 • 200 citations
Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan.
1998 • 176 citations
Potent, orally absorbed glucagon receptor antagonists
1999 • 168 citations
A Small, Nonpeptidyl Mimic of Granulocyte-Colony- Stimulating Factor
1998 • 153 citations
5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V2Receptors
1998 • 144 citations
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
1998 • 128 citations
Discovery of a Novel, Potent, and Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor
1998 • 126 citations
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists
1998 • 122 citations
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
1999 • 90 citations
Novel Nonpeptide CCK-B Antagonists: Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists
1998 • 87 citations
A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-a]pyridine Moiety
1998 • 77 citations
Discovery of a Novel Non-Peptide Somatostatin Agonist with SST4 Selectivity
1998 • 76 citations
Non-peptide ligands for peptide receptors
1989 • 74 citations
Peptidomimetic Growth Hormone Secretagogues. Design Considerations and Therapeutic Potential
1998 • 69 citations
De Novo Design, Synthesis, and Biological Activities of High-Affinity and Selective Non-Peptide Agonists of the δ-Opioid Receptor
1998 • 67 citations
Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines
1999 • 63 citations
2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models
1998 • 63 citations
Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines
1998 • 62 citations
A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation
1998 • 59 citations
The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold
1999 • 57 citations
Identification of an Opioid κ Receptor Subtype-Selective N-Substituent for (+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)piperidine
1998 • 52 citations
PD 176252 — The first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist
1998 • 48 citations
A Potent, Orally Bioavailable Benzazepinone Growth Hormone Secretagogue
1998 • 44 citations
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models
1998 • 43 citations
Second Generation “Peptoid” CCK-B Receptor Antagonists: Identification and Development ofN-(Adamantyloxycarbonyl)-α-methyl-(R)-tryptophan Derivative (CI-1015) with an Improved Pharmacokinetic Profile
1998 • 43 citations
Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino-N- (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308)
1998 • 39 citations
A Novel Class of Orally Active Non-Peptide Bradykinin B2 Receptor Antagonists. 2. Overcoming the Species Difference between Guinea Pig and Man
1998 • 38 citations
Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997
1998 • 35 citations
1-[2(R)-(2-Amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]-3- benzylpiperidine-3(S)-carboxylic Acid Ethyl Ester (L-163,540): A Potent, Orally Bioavailable, and Short-Duration Growth Hormone Secretagogue
1998 • 35 citations
Novel Orally Active Growth Hormone Secretagogues
1998 • 34 citations
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist
1998 • 33 citations
High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template
1998 • 29 citations
4,4-Disubstituted Piperidine High-Affinity NK1 Antagonists: Structure−Activity Relationships and in Vivo Activity
1998 • 28 citations
Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 3. Discovery of a Potent, 2-Nonaryl, Highly Selective ETA Antagonist (A-216546)
1998 • 23 citations
Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization
1999 • 21 citations
Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives
1998 • 19 citations
Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptor-ligand interactions
1998 • 17 citations
Motilides and motilactides: Design and development of motilin receptor agonists as a new class of gastrointestinal prokinetic drugs
1998 • 15 citations
Update on nonpeptide CCK-B receptor antagonists
1998 • 15 citations
3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist
1998 • 14 citations
Synthesis of 9-Deoxo-4‘‘-deoxy-6,9-epoxyerythromycin Derivatives: Novel and Acid-Stable Motilides
1998 • 13 citations
Synthesis of Phenoxyacetic Acid Derivatives as Highly Potent Antagonists of Gastrin/Cholecystokinin-B Receptors. II.
1998 • 11 citations
L-tryptophan urea amides as dual antagonists
1998 • 11 citations
Thieno[2,3-d]pyrimidine-3-acetic Acids A New Class of Nonpeptide Endothelin Receptor Antagonists.
1998 • 10 citations
4-Alkylpiperidines related to SR-48968: Potent antagonists of the neurokinin-2 (NK2) receptor
1998 • 9 citations
Studies on Nonpeptide Angiotensin II Receptor Antagonists. II. Synthesis and Biological Evaluation of 5H-Pyrazolo(1,5-b)(1,2,4)triazole Derivatives with a C-Linked Oxygen Functional Group at the 6-Position.
1998 • 7 citations
Stereoselective synthesis of a novel and bifunctional endothelin antagonist, IRL 3630
1998 • 7 citations